<DOC>
	<DOCNO>NCT02752022</DOCNO>
	<brief_summary>Electronic cigarette ( e-cigarettes ) prove popular meteoric rise usage currently way . People purchase aid give smoking , reduce cigarette consumption , minimise withdrawal symptom occupational environment ban smoking , order continue smoke decrease health risk . Although safety impact health electronic cigarette , especially long-term use , evaluate , generally consider far safe alternative cigarette smoke . Electronic cigarettes generate polycyclic aromatic hydrocarbon , potent class carcinogenic chemical generate combustion tobacco make important contribution cigarette-induced cancer . However , carcinogenic tobacco-specific nitrosamines encounter e-cigarettes detected nicotine cartridge contaminant , albeit low concentration comparison tobacco smoke . Consequently , imperative ascertain toxicity risk ( ) consume nicotine intake electronic cigarette . This European Commission fund study monitor level carcinogenic tobacco-specific nitrosamines urine heavy smoker give smoke completely transition e-cigarette use period 4 week . Levels compound know associated smoking toxicity , DNA adduct DNA methylation , also monitor biological fluid subject . Finally , cigarette craving , mood , anxiety , social anxiety , well-being status stress hormone measure smoker transition e-cigarettes 4 week assess psychological effect transition . The result study provide important information safety effectiveness e-cigarettes smoking cessation investigator anticipate drive policy .</brief_summary>
	<brief_title>Monitoring Transition From Smoking E-cigarettes</brief_title>
	<detailed_description>Established smoker completely stop smoke 4 week instead transition nicotine use electronic cigarette require . They free purchase e-cigarette e-liquid/cartridges choice . Eligible subject ask visit St George 's Clinical Research Facility provide follow sample . Blood , saliva buccal cell collect screening day . 24hr urine , blood , saliva buccal cell collect baseline day 3 , 7 , 21 28 first transition e-cigarette use . Moreover , subject breathalyse carbon monoxide ( CO ) oximeter urine analyse anatabine ass compliance study protocol ( complete refrain use tobacco cigarettes 4 week use e-cigarettes ) . Subjects monitor craving , mood , social anxiety , sleep profile quality life every visit St George 's Clinical Research Facility ( quality life assess baseline day 28 e-cigarette use ) . The subject follow telephone call 6 12 month end e-cigarette intervention monitor smoking/e-cigarette use behaviour participant crave , mood , social anxiety , sleep profile quality life .</detailed_description>
	<criteria>1 . Heavy smoker ( continuous smoke &gt; 10 cigarette per day ) least 6 month willing give smoking switch nicotine contain ecigarettes help quit smoking . 2 . Males female age 1865 year 3 . Subjects must willing able give inform consent 4 . Subjects must understand English sufficient able read understand participant information sheet informed consent form 5 . Subjects opinion Investigator healthy basis medical history questionnaire vital sign 6 . Subjects purchase ecigarettes kit , eliquid and/or cartridge pharmacy , lead super market , establish newsagent chain ) 1 . Severe psychosis , Bipolar Affective Disorder I , prostate cancer , Cushing 's syndrome , severe depression suicidal ideation intention , brain trauma severe neurological disorder ( e.g . panhypopituitarism ) take antidepressant , anxiolytic antipsychotic 2 . Pregnant female lactate mother 3 . History substance abuse alcoholism 4 . History cardiovascular disease ( heart disease , angina , heart attack , high blood pressure , heart surgery ) last 6 month . 5 . Selfdeclared smoker low nondetectable CO reading breath test oxymeter exclude study 6 . Smokers undergo alternative Nicotine Replacement Therapy ( NRT ) /pharmacological treatment smoke cessation ( i.e . nicotine patch , nicotine gum , Champix , bupropion ) 7 . Any condition judgement investigator would preclude participation 8 . Smokers unwilling refrain smoke 4 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>e-cigarettes</keyword>
	<keyword>nitrosamines</keyword>
	<keyword>smoke cessation</keyword>
</DOC>